Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average - Time to Sell?

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.27 and traded as low as $0.25. Northwest Biotherapeutics shares last traded at $0.35, with a volume of 12,179,951 shares trading hands.

Northwest Biotherapeutics Trading Down 33.9 %

The firm has a market cap of $404.86 million, a price-to-earnings ratio of -3.62 and a beta of -0.67. The stock's fifty day moving average price is $0.25 and its 200-day moving average price is $0.27.

Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last posted its earnings results on Monday, March 31st. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $0.23 million during the quarter.

About Northwest Biotherapeutics

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.